XML 84 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Note 5 - Investment Securities
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
5.
Investment Securities
 
CLO Debt Securities
 
The following table summarizes available-for-sale securities in an unrealized position as of
December 31, 2019
:
 
(In thousands)
 
Amortized Cost
   
Gross Unrealized Gains
   
Gross Unrealized Losses
   
Fair Value
   
Number of Positions
 
CLO III subordinated notes
  $
12,277
    $
-
    $
(1,697
)   $
10,580
   
1
 
CLO IV junior subordinated notes
   
26,174
     
-
    $
(2,877
)    
23,297
   
1
 
CLO V junior subordinated notes
   
25,926
     
-
    $
(1,947
)    
23,979
   
1
 
Total
  $
64,377
    $
-
    $
(6,521
)   $
57,856
   
 
 
 
The following table summarizes the fair value and amortized cost of the available-for-sale securities by contractual maturity as of
December 31, 2019
:
 
(In thousands)
 
Available-for-Sale
 
   
Amortized Cost
   
Fair Value
 
5-10 years
  $
38,451
    $
33,877
 
10+ years
   
25,926
     
23,979
 
Total
  $
64,377
    $
57,856
 
 
The following table summarizes the fair value and gross unrealized losses aggregated by category and the length of time that individual securities have been in a continuous unrealized loss position as of
December 31, 2019
:
 
(In thousands)
 
Less than 12 months(1)
   
Greater than 12 months
   
Total
 
   
Fair Value
   
Gross Unrealized Loss
   
Fair Value
   
Gross Unrealized Loss
   
Fair Value
   
Gross Unrealized Loss
 
CLO III subordinated notes
  $
10,580
    $
(1,697
)   $
-
    $
-
    $
10,580
    $
(1,697
)
CLO IV junior subordinated notes
   
23,297
     
(2,877
)    
-
     
-
     
23,297
     
(2,877
)
CLO V junior subordinated notes
   
23,979
     
(1,947
)    
-
     
-
     
23,979
     
(1,947
)
Total
  $
57,856
    $
(6,521
)   $
-
    $
-
    $
57,856
    $
(6,521
)
 
(
1
)
  For all CLO debt securities, the gross unrealized loss is measured since the date of deconsolidation, which was
January 17, 2019
for CLO III and
March 19, 2019
for CLO IV and CLO V.
 
 
           During the
years ended
December 31, 2019
and
2018
, the Company recognized impairment losses on CLO debt securities of
$4.2
 million and
zero
, respectively, due to the fair value of the debt securities being less than amortized cost.
Equity Securities
The Company has equity securities with quoted prices in active markets as well as equity securities without readily determinable fair market values. Equity securities without readily determinable fair market values are valued at cost, less any impairment, plus or minus changes in fair value resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The Company's carrying value of these securities was
$15.8
million and
$0.8
million as of
December 31, 2019
and
December 31, 2018,
respectively. The Company has
no
t
recognized any impairment or upward or downward adjustments during the
years ended
December 31, 2019
and
2018